Anti-CTAG1B monoclonal antibody

Pre-made anti-CTAG1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CTAG1B/CTAG1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-INN006-Ab-1/ GM-Tg-hg-INN006-Ab-2Anti-Human CTAG1B monoclonal antibodyHuman
GM-Tg-rg-INN006-Ab-1/ GM-Tg-rg-INN006-Ab-2Anti-Rat CTAG1B monoclonal antibodyRat
GM-Tg-mg-INN006-Ab-1/ GM-Tg-mg-INN006-Ab-2Anti-Mouse CTAG1B monoclonal antibodyMouse
GM-Tg-cynog-INN006-Ab-1/ GM-Tg-cynog-INN006-Ab-2Anti-Cynomolgus/ Rhesus macaque CTAG1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-INN006-Ab-1/ GM-Tg-felg-INN006-Ab-2Anti-Feline CTAG1B monoclonal antibodyFeline
GM-Tg-cang-INN006-Ab-1/ GM-Tg-cang-INN006-Ab-2Anti-Canine CTAG1B monoclonal antibodyCanine
GM-Tg-bovg-INN006-Ab-1/ GM-Tg-bovg-INN006-Ab-2Anti-Bovine CTAG1B monoclonal antibodyBovine
GM-Tg-equg-INN006-Ab-1/ GM-Tg-equg-INN006-Ab-2Anti-Equine CTAG1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-INN006-Ab-1/ GM-Tg-hg-INN006-Ab-2; GM-Tg-rg-INN006-Ab-1/ GM-Tg-rg-INN006-Ab-2;
GM-Tg-mg-INN006-Ab-1/ GM-Tg-mg-INN006-Ab-2; GM-Tg-cynog-INN006-Ab-1/ GM-Tg-cynog-INN006-Ab-2;
GM-Tg-felg-INN006-Ab-1/ GM-Tg-felg-INN006-Ab-2; GM-Tg-cang-INN006-Ab-1/ GM-Tg-cang-INN006-Ab-2;
GM-Tg-bovg-INN006-Ab-1/ GM-Tg-bovg-INN006-Ab-2; GM-Tg-equg-INN006-Ab-1/ GM-Tg-equg-INN006-Ab-2
Products NameAnti-CTAG1B monoclonal antibody
Formatmab
Target NameCTAG1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CTAG1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-INN006-Ag-1Recombinant multi-species CTAG1B/ CT6.1/ CTAG protein
    ORF Viral VectorvGMLP004592human CTAG1B Lentivirus particle
    ORF Viral VectorpGMLP004592human CTAG1B Lentivirus plasmid


    Target information

    Target IDGM-INN006
    Target NameCTAG1B
    Gene ID1485
    Gene Symbol and SynonymsCT6.1,CTAG,CTAG1,CTAG1B,ESO1,LAGE-2,LAGE2B,NY-ESO-1
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, INN Index
    DiseaseCancer
    Gene EnsemblENSG00000184033
    Target ClassificationTumor-associated antigen (TAA)

    The target: CTAG1B, gene name: CTAG1B, also named as CT6.1, CTAG, CTAG1, ESO1, LAGE-2, LAGE2B, NY-ESO-1. The protein encoded by this gene is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. This gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.